BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,228,000 | +23.5% | 52,000 | 0.0% | 0.34% | +14.0% |
Q4 2018 | $3,423,000 | -14.6% | 52,000 | 0.0% | 0.30% | +3.8% |
Q3 2018 | $4,009,000 | +93.9% | 52,000 | +85.7% | 0.29% | +15.6% |
Q2 2018 | $2,068,000 | +13.6% | 28,000 | 0.0% | 0.25% | +15.2% |
Q1 2018 | $1,821,000 | +0.6% | 28,000 | 0.0% | 0.22% | +5.3% |
Q4 2017 | $1,810,000 | +3.0% | 28,000 | 0.0% | 0.21% | +1.5% |
Q3 2017 | $1,757,000 | +45.1% | 28,000 | +40.0% | 0.20% | -8.6% |
Q2 2017 | $1,211,000 | +16.8% | 20,000 | 0.0% | 0.22% | +18.7% |
Q1 2017 | $1,037,000 | +16.9% | 20,000 | 0.0% | 0.19% | +14.0% |
Q4 2016 | $887,000 | +237.3% | 20,000 | +150.0% | 0.16% | +164.5% |
Q3 2015 | $263,000 | -80.5% | 8,000 | -59.4% | 0.06% | -77.8% |
Q1 2015 | $1,349,000 | -6.6% | 19,700 | 0.0% | 0.28% | -3.1% |
Q4 2014 | $1,444,000 | +2.1% | 19,700 | 0.0% | 0.29% | +4.3% |
Q3 2014 | $1,414,000 | +54.0% | 19,700 | +55.1% | 0.28% | +50.8% |
Q2 2014 | $918,000 | +119.1% | 12,700 | +122.8% | 0.18% | +84.8% |
Q1 2014 | $419,000 | +5.8% | 5,700 | 0.0% | 0.10% | +2.1% |
Q4 2013 | $396,000 | – | 5,700 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |